跳至主要内容
临床试验/EUCTR2006-003567-31-DE
EUCTR2006-003567-31-DE进行中(未招募)不适用

Regulation of Inflammatory Parameters by Telmisartan in Hypertensive Patients

Med. Klinik II, Grosshadern, Klinikum der Universität München0 个研究点开始时间: 2007年3月29日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • age 19-60 yearsAlter 19-60 Jahre
  • abdominal obesity (BMI > 25 kg/m² and waist circumference>=95 cm (male), >=80 cm (female))
  • systolic blood pressure >=130mmHg and/or diastolic blood pressure >=85mmHg
  • Triglycerides 150-400 mg/dl
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Diabetes mellitus (fasting glucose >=126 mg/dl or antidiabetic medication)
  • secondary causes for insulin resistence (e.g. corticosteroids)
  • LDL-cholesterol > 190 mg/dl
  • established atherosclerosis
  • systolic blood pressure >=160mmHg and/or diastolic blood pressure >=100mmHg
  • regular alcohol consumption > 30g/d
  • contra-indications agains ARB
  • anti-hypertensive medication
  • lipid-lowering therapy
  • pregnant or breast-feeding women
  • Women of childbearing potential (WOCBP) must be using an adequate method of contraception to avoid pregnancy throughout the study and up to four weeks after the study in such a manner that the risk of pregnancy is minimized.

研究者

发起方
Med. Klinik II, Grosshadern, Klinikum der Universität München

相似试验